NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia

Nature

Volumn 421, Issue 6923, 2003, Pages 639-643

  Dajee, Maya ^a   Lazarov, Mirella ^a   Zhang, Jennifer Y ^a   Cai, Ti ^a   Green, Cheryl L ^a   Russell, Alan J ^a   Marinkovich, M Peter ^a   Tao, Shlying ^a   Lin, Qun ^a   Kubo, Yoshiaki ^a   Khavari, Paul A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA6BETA4 INTEGRIN; CELL ADHESION MOLECULE; CYCLIN DEPENDENT KINASE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KALININ; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; PROTEIN P21; ALPHA6 INTEGRIN; I KAPPA B ALPHA; RAS PROTEIN;

ANIMAL; APOPTOSIS; ARTICLE; CANCER INVASION; CELL DIVISION; CHEMISTRY; DRUG ANTAGONISM; ENZYMOLOGY; EPIDERMIS; GENETIC TRANSDUCTION; GENETICS; HUMAN; KERATINOCYTE; METABOLISM; MOUSE; MOUSE MUTANT; NEOPLASM; NUDE MOUSE; ONCOGENE RAS; PATHOLOGY; TELOMERE; TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE; CELL PROLIFERATION; ENZYME INHIBITION; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SKIN CANCER; SQUAMOUS CELL CARCINOMA;

ANIMALS; APOPTOSIS; CELL ADHESION MOLECULES; CELL DIVISION; CYCLIN-DEPENDENT KINASES; EPIDERMIS; GENES, RAS; HUMANS; I-KAPPA B PROTEINS; INTEGRIN ALPHA6BETA4; KERATINOCYTES; MICE; MICE, NUDE; MICE, SCID; NEOPLASM INVASIVENESS; NEOPLASMS; NF-KAPPA B; ONCOGENE PROTEIN P21(RAS); TELOMERE; TRANSDUCTION, GENETIC;

CELLS; ONCOLOGY; SKIN; TISSUE;

CARCINOMA;

TUMORS;

MEDICINE;

ANIMALIA; MURINAE;

EID: 0037421484     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature01283     Document Type: Article

References (30)

1. Miller, D. L. & Weinstock, M. A. Nonmelanoma skin cancer in the United States: incidence. J. Am. Acad. Dermatol. 30, 774-778 (1994).
2. Alam, M. & Ratner, D. Cutaneous squamous-cell carcinoma. N. Engl. J. Med. 344, 975-983 (2001).
3. Yuspa, S. H. The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis. The thirty-third G. H. A. Clowes Memorial Award Lecture. Cancer Res. 54, 1178-1189 (1994).
4. Pazzaglia, S. et al. Analysis of c-Ha-ras gene mutations in skin tumors induced in carcinogenesissusceptible and carcinogenesis-resistant mice by different two-stage protocols or tumour promoter alone. Mol. Carcinog. 30, 111-118 (2001).
5. van Hogerlinden, M., Rozell, B. L., Ahrlund-Richter, L. & Toftgard, R. Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-κB signaling. Cancer Res. 59, 3299-3303 (1999).
6. Yamamoto, Y. & Gaynor, R. B. Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer. J. Clin. Invest. 107, 135-142 (2001).
7. Seitz, C. S., Lin, Q., Deng, H. & Khavari, P. A. Alterations in NF-κB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-κB. Proc. Natl Acad. Sci. USA 95, 2307-2312 (1998).
8. Karin, M., Cao, Y., Greten, F. R. & Li, Z. W. NF-κB in cancer: from innocent bystander to major culprit. Nature Rev. Cancer 2, 301-810 (2002).
9. Adjei, A. A. Blocking oncogenic Ras signaling for cancer therapy. J. Natl Cancer Inst. 93, 1062-1074 (2001).
10. Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R. & Verma, I. M. Suppression of TNF-α-induced apoptosis by NF-κB. Science 274, 787-789 (1996).
11. Robbins, P. B. et al. In vivo restoration of laminin 5 β3 expression and function in junctional epidermolysis bullosa. Proc. Natl Acad. Sci. USA 98, 5193-5198 (2001).
12. Mayo, M. W. et al. Requirement of NF-κB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science 278, 1812-1815 (1997).
13. Cogswell, P. C., Guttridge, D. C., Funkhouser, W. K. & Baldwin, A. S. Jr Selective activation of NF-κB subunits in human breast cancer: potential roles for NF-κB2/p52 and for Bcl-3. Oncogene 19, 1123-1131 (2000).
14. Mitchell, C. E., Belinsky, S. A. & Lechner, J. F. Detection and quantitation of mutant K-ras codon 12 restriction fragments by capillary electrophoresis. Anal. Biochem. 224, 148-153 (1995).
15. Seitz, C. S., Deng, H., Hinata, K., Lin, Q. & Khavari, P. A. Nuclear factor κB subunits induce epithelial cell growth arrest. Cancer Res. 60, 4085-4092 (2000).
16. Lazarov, M. et al. CDK4 coexpression with Ras generates malignant human epidermal tumorigenesis. Nature Med. 8, 1105-1114 (2002).
17. Bonni, A. et al. Cell survival promoted by the Ras-MAPK signaling pathway by transcriptiondependent and -independent mechanisms. Science 286, 1358-1362 (1999).
18. Stambolic, V., Mak, T. W. & Woodgett, J. R. Modulation of cellular apoptotic potential: contributions to oncogenesis. Oncogene 18, 6094-6103 (1999).
19. Elenbaas, B. et al. Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev. 15, 50-65 (2001).
20. Watt, F. M. Role of integrins in regulating epidermal adhesion, growth and differentiation. EMBO J. 21, 3919-3926 (2002).
21. Mercurio, A. M. & Rabinovitz, I. Towards a mechanistic understanding of tumour invasion - lessons from the α6β4 integrin. Semin. Cancer Biol. 11, 129-141 (2001).
22. Savoia, P., Trusolino, L., Pepino, E. & Marchisio, P. C. Expression and topography of integrins and basement membrane proteins in epidermal carcinomas: basal but not squamous cell carcinomas display loss of α6β4 and BM-600/nicein. J. Invest. Dermatol. 101, 352-358 (1993).
23. Nordemar, S. et al. Laminin-5 as a predictor of invasiveness in cancer in situ lesions of the larynx. Anticancer Res. 21, 509-512 (2001).
24. Dajee, M., Tarutani, M., Deng, H., Cai, T. & Khavari, P. A. Epidermal Ras blockade demonstrates spatially localized Ras promotion of proliferation and inhibition of differentiation. Oncogene 21, 1527-1538 (2002).
25. Marinkovich, M. P., Herron, G. S., Khavari, P. A. & Bauer, E. A. Dermatology in General Medicine (ed. Freedberg, I. M.) 690-702 (McGraw-Hill, New York, 1999).
26. Zimonjic, D., Brooks, M. W., Popescu, N., Weinberg, R. A. & Hahn, W. C. Derivation of human tumour cells in vitro without widespread genomic instability. Cancer Res. 61, 8838-8844 (2001).
27. Ghosh, S. & Karin, M. Missing pieces in the NF-κB puzzle. Cell 109 (Suppl.), S81-S96 (2002).
28. Pruitt, K. & Der, C. J. Ras and Rho regulation of the cell cycle and oncogenesis. Cancer Lett. 171, 1-10 (2001).
29. Wick, M., Zubov, D. & Hagen, G. Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT). Gene 232, 97-106 (1999).
30. Marinkovich, M. P., Lunstrum, G. P. & Burgeson, R. E. The anchoring filament protein kalinin is synthesized and secreted as a high molecular weight precursor. J. Biol. Chem. 267, 17900-17906 (1992).